DICP OpenIR
Subject Area药学其他学科
Computational studies on drug-drug interactions and drug-metabolism enzyme interactions
Ma H(马红); Fu T(付婷); Li GH(李国辉)
Source PublicationProgram
Conference NameThe 4TH Asia-Pacific Regional Meeting of ISSX on Bridging Drug Research to Regulatory Approval
Conference Date2010-4-22
2011
Conference Place台南
Alternative Title药物相互作用和药物与代谢酶相互作用的计算机研究
Pages0-0
Publisher待补充
Publication Place待补充
Cooperation Status墙报
Department1106
Funding Organization台湾成功大学
AbstractMolecular mechanism of drug-drug interactions and drug-P450 family enzyme interactions are very important for understanding drug metabolism and toxicity, and also guiding drug discovery. The first step for drug-drug interactions and drug-enzyme interactions before their metabolization is the process of drug binding to the metabolism enzyme. This process involves multi-drug binding[1]. Many computational studies have been done to discover different drugs binding to the enzymes but with only one drug molecule involved in the simulation[2, 3]. As lots of experiments have shown that several same and/or different types of drug molecules could bind to the enzyme simultaneously[4, 5]. How does this process happen at atomistic level? Is there time sequencing for different drug molecules binding or not? What is the dynamics behavior of enzyme upon multi-drug binding? Is it different for the enzyme to bind single drug and multi-drug molecules? To uncover these questions, we will adapt two strategies. Firstly, simulated annealing techniques will be used to find the possible initial binding complex structures, and then molecular dynamics will be adapted to relax and finely tune the relative position and orientation of these drug molecules in the binding pocket of enzyme. This two-step modeling procedure will be done many thousands times to find \"good\" binding pose; Second strategy is that multi-copy of drug molecules are included in the molecular dynamics simulation, but the interaction between drug molecules are not calculated at first step, only the interaction involving drug-enzyme and enzyme itself will be computed, at second step the final pose from 1st step will be submitted to the normal molecular dynamics simulation with all the interaction included. Several marketed drugs[6] and p450-3A4 will be selected and tested.; Molecular mechanism of drug-drug interactions and drug-P450 family enzyme interactions are very important for understanding drug metabolism and toxicity, and also guiding drug discovery. The first step for drug-drug interactions and drug-enzyme interactions before their metabolization is the process of drug binding to the metabolism enzyme. This process involves multi-drug binding[1]. Many computational studies have been done to discover different drugs binding to the enzymes but with only one drug molecule involved in the simulation[2, 3]. As lots of experiments have shown that several same and/or different types of drug molecules could bind to the enzyme simultaneously[4, 5]. How does this process happen at atomistic level? Is there time sequencing for different drug molecules binding or not? What is the dynamics behavior of enzyme upon multi-drug binding? Is it different for the enzyme to bind single drug and multi-drug molecules? To uncover these questions, we will adapt two strategies. Firstly, simulated annealing techniques will be used to find the possible initial binding complex structures, and then molecular dynamics will be adapted to relax and finely tune the relative position and orientation of these drug molecules in the binding pocket of enzyme. This two-step modeling procedure will be done many thousands times to find \"good\" binding pose; Second strategy is that multi-copy of drug molecules are included in the molecular dynamics simulation, but the interaction between drug molecules are not calculated at first step, only the interaction involving drug-enzyme and enzyme itself will be computed, at second step the final pose from 1st step will be submitted to the normal molecular dynamics simulation with all the interaction included. Several marketed drugs[6] and p450-3A4 will be selected and tested.
Document Type会议论文
Identifierhttp://cas-ir.dicp.ac.cn/handle/321008/115951
Collection中国科学院大连化学物理研究所
Corresponding AuthorLi GH(李国辉)
Recommended Citation
GB/T 7714
Ma H,Fu T,Li GH. Computational studies on drug-drug interactions and drug-metabolism enzyme interactions[C]. 待补充:待补充,2011:0-0.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[马红]'s Articles
[付婷]'s Articles
[李国辉]'s Articles
Baidu academic
Similar articles in Baidu academic
[马红]'s Articles
[付婷]'s Articles
[李国辉]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[马红]'s Articles
[付婷]'s Articles
[李国辉]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.